Texas A&M: Lab Develops Organ-on-a-Chip to Better Treat Sickle Cell Disease
March 18, 2021
March 18, 2021
COLLEGE STATION, Texas, March 18 (TNSJou) -- Texas A&M University's College of Engineering issued the following news:
Sickle cell disease (SCD) is the most prevalent inherited blood disorder in the world that affects between 70,000 to 100,000 Americans. However, it is considered an orphan disease, meaning it impacts less than 200,000 people nationally, and is therefore underrepresented in therapeutic research. A team led by Dr. Abhishek Jain from the Department of Biomedical Eng . . .
Sickle cell disease (SCD) is the most prevalent inherited blood disorder in the world that affects between 70,000 to 100,000 Americans. However, it is considered an orphan disease, meaning it impacts less than 200,000 people nationally, and is therefore underrepresented in therapeutic research. A team led by Dr. Abhishek Jain from the Department of Biomedical Eng . . .